Cargando…
Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population
BACKGROUND: More than 30% of Medicare beneficiaries and 40% of patients dually eligible for Medicare and Medicaid use opioids. With an estimated 8%-12% of patients developing an opioid use disorder (OUD) after initiating opioids, opioid misuse is a significant public health challenge, especially amo...
Autores principales: | Ferries, Erin, Racsa, Patrick, Bizzell, Brock, Rhodes, Clay, Suehs, Brandon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390915/ https://www.ncbi.nlm.nih.gov/pubmed/33908274 http://dx.doi.org/10.18553/jmcp.2021.27.5.596 |
Ejemplares similares
-
Novel Approach Using Administrative Claims to Evaluate Trends in Oncology Multigene Panel Testing for Patients Enrolled in Medicare Advantage Health Plans
por: Caplan, Eleanor O., et al.
Publicado: (2021) -
Comparison of Low-Value Services Among Medicare Advantage and Traditional Medicare Beneficiaries
por: Boudreau, Emily, et al.
Publicado: (2022) -
Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D
por: Naci, Huseyin, et al.
Publicado: (2023) -
Measuring the Scope of Prior Authorization Policies: Applying Private Insurer Rules to Medicare Part B
por: Schwartz, Aaron L., et al.
Publicado: (2021) -
Evaluation of Prior Authorization in Medicare Nonemergent Ambulance Transport
por: Contreary, Kara, et al.
Publicado: (2022)